Global Lung Cancer Surgery Market (Devices & Treatment Outlook) - Trends & Challenges (2010 - 2015)
NEW YORK, Aug. 17, 2011 /PRNewswire/ -- Reportlinker.com announces that a new market research report is available in its catalogue:
Global Lung Cancer Surgery Market (Devices & Treatment Outlook) – Trends & Challenges (2010 – 2015)
http://www.reportlinker.com/p0592168/Global-Lung-Cancer-Surgery-Market-Devices--Treatment-Outlook-–-Trends--Challenges-2010-–-2015.html#utm_source=prnewswire&utm_medium=pr&utm_campaign=Pathology
Report Description:
Lung cancer is the most common type of cancer across the globe. According to WHO, lung cancer is expected to be more prominent in the underdeveloped world due to an increase in the use of tobacco products; tobacco is the primary cause of around 80% of all lung cancers. Global incidence of lung cancer was 1,608,055 in 2008 with the developing countries accounting for a major share (55%); 1,694,277 new cases were recorded in 2010 with 1,934,467, 2,213,561, and 2,530,820 as the predicted new cases for the years 2015, 2020, and 2025 respectively.
The lung cancer surgery market is expected to grow at a CAGR of 4.9% during the study period (2010-2015). Thoracotomy is the most widely used surgical procedure for lung cancer treatment accounting for about 74% of all surgical interventions. The market for lung cancer surgeries was valued at $36 billion in 2010 and is expected to grow to $45 billion by 2015. Rising incidence of non-small cell lung cancer globally is the major growth driver for the lung cancer surgery market. Europe accounted for the highest number (40%) of lung cancer surgeries performed in 2010.
Scope of the report
This research report categorizes the lung cancer surgery market on the basis of types of lung cancer surgery procedures, by products, and geography; forecasting revenues and analyzing trends in each of the following submarkets:
On the basis of types of surgeries:
Thoracotomy, minimally invasive procedures like video assisted surgery and robotic surgery
On the basis of products:
Surgical devices, monitoring & visualizing systems and endosurgical equipments
On the basis of geography:
North America, Europe, Rest of the World (ROW)
Each section will provide market data, market drivers, trends and opportunities, top-selling products, key players, and competitive outlook. This report will also provide market tables for covering the sub-segments and micro-markets. In addition, the report also provides more than 19 company profiles covering all the sub-segments.
What makes our reports unique?
We provide the longest market segmentation chain in this industry.
We provide 10% customization. Our customization will ensure that you necessarily get the market intelligence you are looking for and we get a loyal customer.
We conduct detailed market positioning, product positioning, and competitive positioning. Entry strategies, gaps, and opportunities are identified for all the stakeholders.
Comprehensive market analysis for the following sectors:
Pharmaceuticals, Medical Devices, Biotechnology, Semiconductor and Electronics, Energy and Power Supplies, Food and Beverages, Chemicals, Advanced Materials, Industrial Automation, and Telecom and IT. We also analyze retailers and super-retailers, technology providers, and research and development (R&D) companies.
Key questions answered
Which are the high-growth segments/cash cows and how is the market segmented in terms of applications and materials?
What are market estimates and forecasts; which markets are doing well and which are not?
Where are the gaps and opportunities; what is driving the market?
Which are the key playing fields? Which are the winning edge imperatives?
How is the competitive outlook; who are the main players in each of the segments; what are the key selling products; what are their strategic directives, operational strengths and product pipelines? Who is doing what?
Powerful research and analysis
The analysts working with MarketsandMarkets come from renowned publishers and market research firms, globally, adding their expertise and domain understanding. We get the facts from over 22,000 news and information sources, a huge database of key industry participants and draw on our relationships with more than 900 market research companies across the world. We, at MarketsandMarkets, are inspired to help our clients grow by providing qualitative business insights with our huge market intelligence repository.
TABLE OF CONTENTS
1 INTRODUCTION
1.1 KEY TAKE-AWAYS
1.2 REPORT DESCRIPTION
1.3 MARKETS COVERED
1.4 STAKEHOLDERS
1.5 RESEARCH METHODOLOGY
1.5.1 MARKET SIZE
1.5.2 KEY DATA POINTS FROM SECONDARY SOURCES
1.5.3 KEY DATA POINTS FROM PRIMARY SOURCES
1.5.4 ASSUMPTIONS MADE FOR THE REPORT
2 EXECUTIVE SUMMARY
2.1 OVERVIEW OF THE MARKET
2.2 KEY FINDINGS
2.3 RECOMMENDATIONS
2.3.1 DEVICE: ENDOSCOPES
2.3.1.1 Need for an assistant during surgery to handle the endoscope
2.3.1.1.1 Recommendation - head mounted display with motor sensors
2.3.1.2 Paradox view
2.3.1.2.1 Recommendation - use of diverter swich
2.3.2 PROCESS: NUMBER & SIZE OF INCISIONS
2.3.2.1 3 to 4 access ports for performing VATS surgery
2.3.2.1.1 Recommendation - Natural Orifice Transesophageal Endoscopic Surgery (NOTES)
2.3.3 DEVICE: SURGICAL STAPLERS & CUTTERS (SURGICAL DEVICES)
2.3.3.1 Compression of intercostal nerves during surgery
2.3.3.1.1 Recommendation - Light weight surgical devices
2.3.3.2 Restricted maneuverability
2.3.3.2.1 Recommendation - Flexible devices
2.3.4 COMBINATION THERAPY
3 MARKET OVERVIEW
3.1 INTRODUCTION
3.2 MARKET DEFINITION
3.2.1 LUNG CANCER SURGERY MARKET
3.2.2 FUTURE OF LUNG CANCER SURGERY MARKET
3.2.3 LUNG CANCER SURGERY PRODUCT MARKET
3.3 BURNING ISSUES
3.3.1 SURVIVAL ON A SINGLE LUNG DURING SURGERY
3.3.2 ATRIAL FIBRILLATION & ATRIAL FLUTTER
3.3.3 PULMONARY ARTERIAL HYPERTENSION
3.3.4 THROMBOEMBOLISM
3.4 MARKET TRENDS
3.4.1 VATS
3.4.2 ROBOTIC SURGERY
3.4.3 STEREOTACTIC RADIATION THERAPY
3.4.3.1 CyberKnife system
3.5 WINNING IMPERATIVES
3.5.1 EARLY DIAGNOSIS
3.5.1.1 Using PET scan, MRI scan, CT scan & radiopharmaceuticals
3.5.2 POWERED SURGICAL DEVICES
3.5.2.1 Enhanced precision of surgical lasers, cutting instruments, electrosurgery devices
3.5.3 VATS
3.5.3.1 Thoracoscopes and other surgical equipment related to minimally invasive lung surgery
3.6 UNMET NEEDS/GAPS
3.6.1 EARLY DIAGNOSIS
3.6.2 RELAPSE OF LUNG CANCER AFTER SURGICAL RESECTION
3.7 REIMBURSEMENT SCENARIO
3.7.1 U.S.
3.7.2 CANADA
3.7.3 UK
3.7.4 GERMANY
3.7.5 FRANCE
3.7.6 ITALY
3.7.7 SPAIN
3.8 MARKET DYNAMICS
3.8.1 DRIVERS & RESTRAINTS
3.8.1.1 Increasing number of people undergoing surgical interventions
3.8.1.2 Favorable reimbursement scenario in the developed countries favors the market for lung cancer surgery
3.8.1.3 Innovations in diagnosis and alternate treatment therapies hinder the surgery market for lung cancer
3.8.2 CHALLENGES
3.8.2.1 Surgeons
3.8.2.1.1 Air leaks
3.8.2.1.2 Inoperable tumors due to size/location
3.8.2.1.3 Movement of tumors due to breathing during surgery
3.8.2.2 Patients & caregivers
3.8.2.2.1 Accumulation of fluids in chest
3.8.2.2.2 Shortness of breath
3.8.2.2.3 Pain due to surgery
3.8.2.2.4 Bleeding
3.8.3 TECHNOLOGY OVERVIEW
3.8.4 END-USER ANALYSIS
3.8.5 MARKET SHARE OF MAJOR PLAYERS
3.8.6 FUTURE TRENDS: PIPELINE PROCEDURES
4 LUNG SURGERY MARKET, BY TYPES
4.1 INTRODUCTION
4.2 THORACOTOMY
4.3 MINIMALLY INVASIVE PROCEDURES
4.3.1 VIDEO-ASSISTED THORACOSCOPIC SURGERY (VATS)
4.3.2 ROBOTIC SURGERY
4.3.3 OTHERS
4.3.3.1 Endobronchial electrosurgery
4.3.3.2 Percutaneous transcatheter surgery
4.3.3.2.1 Radiofrequency ablation
4.3.3.2.2 Microwave ablation
4.3.3.2.3 Cryoablation
5 LUNG CANCER SURGERY MARKET, BY PRODUCTS
5.1 INTRODUCTION
5.2 SURGICAL DEVICES
5.2.1 HAND INSTRUMENTS
5.2.2 POWERED SURGICAL INSTRUMENTS
5.2.2.1 Lasers
5.2.2.2 Electrosurgical and auxiliary equipment
5.3 MONITORING & VISUALIZING SYSTEMS
5.3.1 CAMERAS & VIDEO SUPPORT
5.3.2 ENDOSCOPIC TROCARS WITH OPTICAL VIEW
5.4 ENDOSURGICAL EQUIPMENT
5.4.1 ENDOSCOPE
5.4.2 MEDICAL ROBOTICS
5.4.2.1 Surgical robots
5.4.2.2 Digital operating rooms
5.4.2.3 Surgical navigation systems
6 GEOGRAPHIC ANALYSIS
6.1 NORTH AMERICA
6.1.1 U.S.
6.1.2 CANADA
6.2 EUROPE
6.2.1 UK
6.2.2 FRANCE
6.2.3 ITALY
6.2.4 SPAIN
6.2.5 GERMANY
6.2.6 REST OF EUROPE
6.3 REST OF THE WORLD
7 COMPETITIVE LANDSCAPE
8 COMPANY PROFILES
8.1 ACCURAY INC.
8.1.1 OVERVIEW
8.1.2 FINANCIALS
8.1.3 PRODUCTS & SERVICES
8.1.4 STRATEGY
8.1.5 DEVELOPMENTS
8.2 ANGIODYNAMICS
8.2.1 OVERVIEW
8.2.2 FINANCIALS
8.2.3 PRODUCTS & SERVICES
8.2.4 STRATEGY
8.2.5 DEVELOPMENTS
8.3 BSD MEDICAL CORP
8.3.1 OVERVIEW
8.3.2 FINANCIALS
8.3.3 PRODUCTS & SERVICES
8.3.4 STRATEGY
8.3.5 DEVELOPMENTS
8.4 COVIDIEN
8.4.1 OVERVIEW
8.4.2 FINANCIALS
8.4.3 PRODUCTS & SERVICES
8.4.4 STRATEGY
8.4.5 DEVELOPMENTS
8.5 ETHICON ENDO-SURGERY INC.
8.5.1 OVERVIEW
8.5.2 FINANCIALS
8.5.3 PRODUCTS & SERVICES
8.5.4 STRATEGY
8.5.5 DEVELOPMENTS
8.6 NEOMEND INC.
8.6.1 OVERVIEW
8.6.2 FINANCIALS
8.6.3 PRODUCTS & SERVICES
8.6.4 STRATEGY
8.6.5 DEVELOPMENTS
8.7 OLYMPUS CORP
8.7.1 OVERVIEW
8.7.2 FINANCIALS
8.7.3 PRODUCTS & SERVICES
8.7.4 STRATEGY
8.7.5 DEVELOPMENTS
8.8 RICHARD WOLF GMBH
8.8.1 OVERVIEW
8.8.2 PRODUCTS & SERVICES
8.8.3 STRATEGY
8.8.4 DEVELOPMENTS
8.9 SIEMENS HEALTHCARE
8.9.1 OVERVIEW
8.9.2 FINANCIALS
8.9.3 PRODUCTS & SERVICES
8.9.4 STRATEGY
8.9.5 DEVELOPMENTS
8.10 OTHERS
8.10.1 ACKERMANN INSTRUMENTE GMBH
8.10.1.1 Overview
8.10.1.2 Products & services
8.10.2 APOLLO SURGICAL INDUSTRIES INC. (ASI)
8.10.2.1 Overview
8.10.2.2 Products & services
8.10.3 ATRIUM MEDICAL CORPORATION
8.10.3.1 Overview
8.10.3.2 Financials
8.10.3.3 Products & services
8.10.3.4 Strategy
8.10.4 DIMEDA SURGICAL INSTRUMENTS
8.10.4.1 Overview
8.10.4.2 Products & services
8.10.5 INTUITIVE SURGICAL INC.
8.10.5.1 Overview
8.10.5.2 Financials
8.10.5.3 Products & services
8.10.5.4 Strategy
8.10.6 SCANLAN INTERNATIONAL INC.
8.10.6.1 Overview
8.10.6.2 Primary business
8.10.6.3 Products & services
8.10.7 TELEFLEX INC.
8.10.7.1 Overview
8.10.7.2 Financials
8.10.7.3 Products & services
8.10.7.4 Strategy
8.10.8 KARL STORZ GMBH & CO. KG
8.10.8.1 Overview
8.10.8.2 Financials
8.10.8.3 Products & services
8.10.8.4 Strategy
8.10.9 TROKAMED GMBH
8.10.9.1 Overview
8.10.9.2 Products & services
LIST OF TABLES
TABLE 1 ASSUMPTIONS FOR PROCEDURES
TABLE 2 ASSUMPTIONS FOR DEVICES
TABLE 3 ASSUMPTIONS FOR MARKET SHARE
TABLE 4 GLOBAL NSCLC SURGERY PROCEDURES, BY REVENUE, 2008 – 2015 ($MILLION)
TABLE 5 MOLECULAR TARGETED THERAPIES IN CLINICAL TRIALS
TABLE 6 NSCLC STAGE I & II: SURVIVAL RATES
TABLE 7 STAGE I NSCLC RESECTION: RECURRENCE RATES
TABLE 8 OUTCOME OF SURGICAL RESECTION
TABLE 9 SURGEONS: UNMET NEEDS
TABLE 10 PATIENTS & CAREGIVERS: UNMET NEEDS
TABLE 11 AIR LEAK SEALANTS
TABLE 12 INCIDENCE OF FAILURE DURING INFLATION
TABLE 13 END-USER SEGMENTS FOR LUNG CANCER SURGERIES
TABLE 14 PIPELINE PROCEDURES FOR LUNG CANCER SURGERY
TABLE 15 VATS VS OPEN SURGERY
TABLE 16 HOSPITAL STAY & COST COMPARISON OF OPEN SURGERY VS VATS VS ROBOTIC SURGERY
TABLE 17 GLOBAL NSCLC SURGERY PROCEDURES, 2008 – 2015 (NO. OF PROCEDURES)
TABLE 18 GLOBAL THORACOTOMY SURGERY PROCEDURES, 2008 – 2015 (NO. OF PROCEDURES)
TABLE 19 GLOBAL THORACOTOMY SURGERY PROCEDURES, BY REVENUE, 2008 – 2015 ($MILLION)
TABLE 20 GLOBAL VATS SURGERY PROCEDURES, 2008 – 2015 (NO. OF PROCEDURES)
TABLE 21 GLOBAL VATS SURGERY PROCEDURES, BY REVENUE, 2008 – 2015 ($MILLION)
TABLE 22 ROBOTIC SURGERY: ADVANTAGES & DISADVANTAGES
TABLE 23 ROBOTIC PROCEDURES MARKET, BY GEOGRAPHY, 2008 – 2015 (NO. OF PROCEDURES)
TABLE 24 ROBOTIC PROCEDURES MARKET REVENUE, BY GEOGRAPHY, 2008 – 2015 ($MILLION)
TABLE 25 OTHER PROCEDURES MARKET, BY GEOGRAPHY, 2008 – 2015 (NO. OF PROCEDURES)
TABLE 26 OTHER PROCEDURES MARKET REVENUE, BY GEOGRAPHY, 2008 – 2015 ($MILLION)
TABLE 27 LUNG CANCER SURGERY MARKET REVENUE, BY PRODUCTS, 2008 – 2015 ($MILLION)
TABLE 28 LUNG CANCER SURGICAL DEVICES MARKET REVENUE, BY PRODUCTS, 2008 – 2015 ($MILLION)
TABLE 29 LUNG CANCER SURGERY: HAND INSTRUMENTS MARKET REVENUE, BY PRODUCTS, 2008 – 2015 ($THOUSAND)
TABLE 30 LUNG CANCER SURGERY: POWERED DEVICES MARKET REVENUE, BY PRODUCTS, 2008 - 2015 ($MILLION)
TABLE 31 LUNG CANCER SURGERY: MONITORING & VISUALIZATION SYSTEMS MARKET REVENUE, BY PRODUCTS, 2008 - 2015 ($MILLION)
TABLE 32 LUNG CANCER SURGERY: ENDOSURGICAL EQUIPMENT MARKET REVENUE, BY PRODUCTS, 2008 – 2015 ($MILLION)
TABLE 33 U.S: NSCLC SURGERY PROCEDURES, 2008 – 2015 (NO. OF PROCEDURES)
TABLE 34 U.S: NSCLC SURGERY PROCEDURES, BY REVENUE, 2008 – 2015 ($MILLION)
TABLE 35 U.S: THRORACOTOMY SURGERY PROCEDURES, 2008 – 2015 (NO. OF PROCEDURES)
TABLE 36 U.S: THORACOTOMY SURGERY PROCEDURES, BY REVENUE, 2008 – 2015 ($MILLION)
TABLE 37 U.S: VATS SURGERY PROCEDURES, 2008 – 2015 (NO. OF PROCEDURES)
TABLE 38 U.S: VATS SURGERY PROCEDURES, BY REVENUE, 2008 – 2015 ($MILLION)
TABLE 39 U.S: LUNG CANCER SURGERY MARKET REVENUE, BY PRODUCTS, 2008 – 2015 ($MILLION)
TABLE 40 CANADA: NSCLC SURGERY PROCEDURES, 2008 – 2015 (NO. OF PROCEDURES)
TABLE 41 CANADA: NSCLC SURGERY PROCEDURES, BY REVENUE, 2008 – 2015 ($MILLION)
TABLE 42 CANADA: THRORACOTOMY SURGERY PROCEDURES, 2008 – 2015 (NO. OF PROCEDURES)
TABLE 43 CANADA: THORACOTOMY SURGERY PROCEDURES, BY REVENUE, 2008 – 2015 ($MILLION)
TABLE 44 CANADA: VATS SURGERY PROCEDURES, 2008 – 2015 (NO. OF PROCEDURES)
TABLE 45 CANADA: VATS SURGERY PROCEDURES, BY REVENUE, 2008 – 2015 ($MILLION)
TABLE 46 CANADA: LUNG CANCER SURGERY MARKET REVENUE, BY PRODUCTS, 2008 – 2015 ($MILLION)
TABLE 47 UK: NSCLC SURGERY PROCEDURES, 2008 – 2015 (NO. OF PROCEDURES)
TABLE 48 UK: NSCLC SURGERY PROCEDURES, BY REVENUE, 2008 – 2015 ($MILLION)
TABLE 49 UK: THRORACOTOMY SURGERY PROCEDURES, 2008 – 2015 (NO. OF PROCEDURES)
TABLE 50 UK: THORACOTOMY SURGERY PROCEDURES, BY REVENUE, 2008 – 2015 ($MILLION)
TABLE 51 UK: VATS SURGERY PROCEDURES, 2008 – 2015 (NO. OF PROCEDURES)
TABLE 52 UK: VATS SURGERY PROCEDURES, BY REVENUE, 2008 – 2015 ($MILLION)
TABLE 53 UK: LUNG CANCER SURGERY MARKET REVENUE, BY PRODUCTS, 2008 – 2015 ($MILLION)
TABLE 54 FRANCE: NSCLC SURGERY PROCEDURES, 2008 – 2015 (NO. OF PROCEDURES)
TABLE 55 FRANCE: NSCLC SURGERY PROCEDURES, BY REVENUE, 2008 – 2015 ($MILLION)
TABLE 56 FRANCE: THRORACOTOMY SURGERY PROCEDURES, 2008 – 2015 (NO. OF PROCEDURES)
TABLE 57 FRANCE: THORACOTOMY SURGERY PROCEDURES, BY REVENUE, 2008 – 2015 ($MILLION)
TABLE 58 FRANCE: VATS SURGERY PROCEDURES, 2008 – 2015 (NO. OF PROCEDURES)
TABLE 59 FRANCE: VATS SURGERY PROCEDURES, BY REVENUE, 2008 – 2015 ($MILLION)
TABLE 60 FRANCE: LUNG CANCER SURGERY MARKET REVENUE, BY PRODUCTS, 2008 – 2015 ($MILLION)
TABLE 61 ITALY: NSCLC SURGERY PROCEDURES, 2008 – 2015 (NO. OF PROCEDURES)
TABLE 62 ITALY: NSCLC SURGERY PROCEDURES, BY REVENUE, 2008 – 2015 ($MILLION)
TABLE 63 ITALY: THRORACOTOMY SURGERY PROCEDURES, 2008 – 2015 (NO. OF PROCEDURES)
TABLE 64 ITALY: THORACOTOMY SURGERY PROCEDURES, BY REVENUE, 2008 – 2015 ($MILLION)
TABLE 65 ITALY: VATS SURGERY PROCEDURES, 2008 – 2015 (NO. OF PROCEDURES)
TABLE 66 ITALY: VATS SURGERY PROCEDURES, BY REVENUE, 2008 – 2015 ($MILLION)
TABLE 67 ITALY: LUNG CANCER SURGERY MARKET REVENUE, BY PRODUCTS, 2008 - 2015 ($MILLION)
TABLE 68 SPAIN: NSCLC SURGERY PROCEDURES, 2008 – 2015 (NO. OF PROCEDURES)
TABLE 69 SPAIN: NSCLC SURGERY PROCEDURES, BY REVENUE, 2008 – 2015 ($MILLION)
TABLE 70 SPAIN: THRORACOTOMY SURGERY PROCEDURES, 2008 – 2015 (NO. OF PROCEDURES)
TABLE 71 SPAIN: THORACOTOMY SURGERY PROCEDURES, BY REVENUE, 2008 – 2015 ($MILLION)
TABLE 72 SPAIN: VATS SURGERY PROCEDURES, 2008 – 2015 (NO. OF PROCEDURES)
TABLE 73 SPAIN: VATS SURGERY PROCEDURES, BY REVENUE, 2008 – 2015 ($MILLION)
TABLE 74 SPAIN: LUNG CANCER SURGERY MARKET REVENUE, BY PRODUCTS, 2008 – 2015 ($MILLION)
TABLE 75 GERMANY NSCLC SURGERY PROCEDURES, 2008 – 2015 (NO. OF PROCEDURES)
TABLE 76 GERMANY: NSCLC SURGERY PROCEDURES, BY REVENUE, 2008 – 2015 ($MILLION)
TABLE 77 GERMANY: THRORACOTOMY SURGERY PROCEDURES, 2008 – 2015 (NO. OF PROCEDURES)
TABLE 78 GERMANY: THORACOTOMY SURGERY PROCEDURES, BY REVENUE, 2008 – 2015 ($MILLION)
TABLE 79 GERMANY: VATS SURGERY PROCEDURES, 2008 – 2015 (NO. OF PROCEDURES)
TABLE 80 GERMANY: VATS SURGERY PROCEDURES, BY REVENUE, 2008 – 2015 ($MILLION)
TABLE 81 GERMANY: LUNG CANCER SURGERY MARKET REVENUE, BY PRODUCTS, 2008 – 2015 ($MILLION)
TABLE 82 ROE: NSCLC SURGERY PROCEDURES, 2008 – 2015 (NO. OF PROCEDURES)
TABLE 83 ROE: NSCLC SURGERY PROCEDURES, BY REVENUE, 2008 – 2015 ($MILLION)
TABLE 84 ROE: THORACOTOMY SURGERY PROCEDURES, 2008 – 2015 (NO. OF PROCEDURES)
TABLE 85 ROE: THORACOTOMY SURGERY PROCEDURES, BY REVENUE, 2008 – 2015 ($MILLION)
TABLE 86 ROE: VATS SURGERY PROCEDURES, 2008 – 2015 (NO. OF PROCEDURES)
TABLE 87 ROE: VATS SURGERY PROCEDURES, BY REVENUE, 2008 – 2015 ($MILLION)
TABLE 88 ROE: LUNG CANCER SURGERY MARKET REVENUE, BY PRODUCTS, 2008 – 2015 ($MILLION)
TABLE 89 ROW: NSCLC SURGERY PROCEDURES, 2008 – 2015 (NO. OF PROCEDURES)
TABLE 90 ROW: NSCLC SURGERY PROCEDURES, BY REVENUE, 2008 – 2015 ($MILLION)
TABLE 91 ROW: THRORACOTOMY SURGERY PROCEDURES, 2008 – 2015 (NO. OF PROCEDURES)
TABLE 92 ROW: THORACOTOMY SURGERY PROCEDURES, BY REVENUE, 2008 – 2015 ($MILLION)
TABLE 93 ROW: VATS SURGERY PROCEDURES, 2008 – 2015 (NO. OF PROCEDURES)
TABLE 94 ROW: VATS SURGERY PROCEDURES, BY REVENUE, 2008 – 2015 ($MILLION)
TABLE 95 ROW: LUNG CANCER SURGERY MARKET REVENUE, BY PRODUCTS, 2008 – 2015 ($MILLION)
TABLE 96 NEW PRODUCT LAUNCHES, 2008 – 2011
TABLE 97 AGREEMENTS & COLLABORATIONS, 2008 – 2010
TABLE 98 MERGERS & ACQUISITIONS
TABLE 99 APPROVALS, 2008 – 2011
TABLE 100 ACCURAY: TOTAL REVENUE AND R&D EXPENDITURE, 2008 – 2010 ($THOUSAND)
TABLE 101 ACCURAY: CYBERKNIFE SYSTEM INSTALLATIONS, BY GEOGRAPHY, 2007 - 2010 (UNITS)
TABLE 102 ANGIODYNAMICS: TOTAL REVENUE AND R&D EXPENDITURE, 2008 – 2010 ($THOUSAND)
TABLE 103 ANGIODYNAMICS: BUSINESS SEGMENT REVENUE, 2008 – 2010 ($THOUSAND)
TABLE 104 ANGIODYNAMICS: REVENUE, BY GEOGRAPHY, 2008 – 2010 ($THOUSAND)
TABLE 105 BSD MEDICAL CORPORATION: REVENUE AND R&D EXPENDITURE, 2008 – 2010 ($MILLION)
TABLE 106 COVIDIEN: REVENUE AND R&D EXPENDITURE, 2008 – 2010 ($MILLION)
TABLE 107 COVIDIEN: REVENUE, BY SEGMENT, 2008 – 2010 ($MILLION)
TABLE 108 COVIDIEN: MEDICAL DEVICES SEGMENT REVENUE, 2008 – 2010 ($MILLION)
TABLE 109 COVIDIEN: REVENUE, BY GEOGRAPHY, 2008 – 2010 ($MILLION)
TABLE 110 ETHICON ENDO-SURGERY (EES): REVENUE 2008 – 2010 ($MILLION)
TABLE 111 OLYMPUS CORPORATION: REVENUE AND R&D EXPENDITURE, 2008 – 2010 ($MILLION)
TABLE 112 OLYMPUS CORPORATION: REVENUE, BY SEGMENTS, 2008 – 2010 ($MILLION)
TABLE 113 OLYMPUS CORPORATION: REVENUE, BY GEOGRAPHY, 2008 – 2010 ($MILLION)
TABLE 114 SIEMENS HEALTHCARE: REVENUE AND R&D EXPENDITURE, 2008 – 2010 ($MILLION)
TABLE 115 INTUITIVE SURGICAL: REVENUE AND R&D EXPENSES, 2007 – 2009 ($THOUSAND)
TABLE 116 TELEFLEX: REVENUE, BY SEGMENT, 2008 – 2010 ($THOUSAND)
TABLE 117 TELEFLEX: REVENUE, BY GEOGRAPHY, 2008 – 2010 ($THOUSAND)
LIST OF FIGURES
FIGURE 1 INNOVATIONS IN SURGICAL TREATMENT OF LUNG CANCER
FIGURE 2 LUNG CANCER OVERVIEW: A CHALLENGING DISEASE
FIGURE 3 LUNG CANCER: DISEASE CLASSIFICATION & TREATMENT MODES
FIGURE 4 LUNG CANCER: SURGERY MARKET SEGMENTATION
FIGURE 5 UNMET NEEDS IN LUNG CANCER SURGERY
FIGURE 6 MARKET SHARE ANALYSIS (2010)
FIGURE 7 LUNG CANCER: TREATMENT
FIGURE 8 LUNG CANCER SURGICAL INTERVENTION
FIGURE 9 SURGICAL PROCEDURES: DIAGRAMMATIC OVERVIEW 1
FIGURE 10 SURGICAL PROCEDURES: DIAGRAMMATIC OVERVIEW 2
FIGURE 11 CYBERKNIFE & ROBOTIC SURGERY
FIGURE 12 MARKET SEGMENTATION
FIGURE 13 MAJOR GROWTH STRATEGIES IN LUNG CANCER SURGERY MARKET (JANUARY 2008 – MARCH 2011)
To order this report:
Pathology Industry: Global Lung Cancer Surgery Market (Devices & Treatment Outlook) – Trends & Challenges (2010 – 2015)
Pathology Business News
Check our Company Profile, SWOT and Revenue Analysis!
Nicolas Bombourg
Reportlinker
Email: [email protected]
US: (805)652-2626
Intl: +1 805-652-2626
SOURCE Reportlinker
Share this article